Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Investigating excitatory GABAergic signalling & benzodiazepine resistance in an in vitro model of status epilepticus

Status epilepticus (SE) describes a state of persistent seizures which are unrelenting. First- line treatment for status epilepticus uses a group of drugs, the benzodiazepines, that promote the action of the major inhibitory neurotransmitter within the brain, gamma (γ)-aminobutyric acid (GABA). In a...

Full description

Saved in:
Bibliographic Details
Main Author: Burman, Richard J
Other Authors: Raimondo, Joseph V
Format: Thesis
Language:English
Published: Division of Medical Biochemistry and Structural Biology 2018
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613811880493056
access_status_str Open Access
author Burman, Richard J
author2 Raimondo, Joseph V
author_browse Burman, Richard J
Raimondo, Joseph V
author_facet Raimondo, Joseph V
Burman, Richard J
author_sort Burman, Richard J
collection Thesis
description Status epilepticus (SE) describes a state of persistent seizures which are unrelenting. First- line treatment for status epilepticus uses a group of drugs, the benzodiazepines, that promote the action of the major inhibitory neurotransmitter within the brain, gamma (γ)-aminobutyric acid (GABA). In a subset of patients however, benzodiazepines prove to be ineffective in terminating SE. Previous data from in vitro models has demonstrated that during single seizures, instead of being inhibitory, activation of the GABAA receptor can have an excitatory effect on neurons. To date, it is unknown whether this shift in GABAergic function contributes to SE, nor how it may modulate the anticonvulsant properties of benzodiazepines. In this thesis I explore the role of excitatory GABAergic signaling in an in vitro model of SE and how this may affect the anticonvulsant efficacy of the benzodiazepine, diazepam. Firstly, I confirm that benzodiazepine-resistant SE is prevalent in a South African paediatric population. Secondly, consistent with its established mechanism of action, I show that diazepam enhances GABAAR synaptic currents. Thirdly, using the in vitro 0 Mg²⁺ model of status epilepticus I show that whilst early application of diazepam has anticonvulsant properties, this is lost when the drug is applied during prolonged epileptiform activity. Fourthly, to investigate this phenomenon I use optogenetic activation of GABAergic interneurons to show that interneurons can drive epileptiform discharges during SE-like activity in vitro. Finally, I confirm that during seizure-like events there is a transient shift in GABAergic signaling that is caused by activity driven changes in the transmembrane Cl⁻ gradient. This thesis provides insight into how excitatory GABAergic signaling during prolonged seizures may contribute towards benzodiazepine resistance in SE. I believe that these results are relevant for understanding of the pathophysiology of SE and may help inform optimal treatment protocols for this condition.
format Thesis
id oai:open.uct.ac.za:11427/27886
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:42:05.356Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2018
publishDateRange 2018
publishDateSort 2018
publisher Division of Medical Biochemistry and Structural Biology
publisherStr Division of Medical Biochemistry and Structural Biology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/27886 Investigating excitatory GABAergic signalling & benzodiazepine resistance in an in vitro model of status epilepticus Burman, Richard J Raimondo, Joseph V Katz, Arieh A Medical Biochemistry Status epilepticus (SE) describes a state of persistent seizures which are unrelenting. First- line treatment for status epilepticus uses a group of drugs, the benzodiazepines, that promote the action of the major inhibitory neurotransmitter within the brain, gamma (γ)-aminobutyric acid (GABA). In a subset of patients however, benzodiazepines prove to be ineffective in terminating SE. Previous data from in vitro models has demonstrated that during single seizures, instead of being inhibitory, activation of the GABAA receptor can have an excitatory effect on neurons. To date, it is unknown whether this shift in GABAergic function contributes to SE, nor how it may modulate the anticonvulsant properties of benzodiazepines. In this thesis I explore the role of excitatory GABAergic signaling in an in vitro model of SE and how this may affect the anticonvulsant efficacy of the benzodiazepine, diazepam. Firstly, I confirm that benzodiazepine-resistant SE is prevalent in a South African paediatric population. Secondly, consistent with its established mechanism of action, I show that diazepam enhances GABAAR synaptic currents. Thirdly, using the in vitro 0 Mg²⁺ model of status epilepticus I show that whilst early application of diazepam has anticonvulsant properties, this is lost when the drug is applied during prolonged epileptiform activity. Fourthly, to investigate this phenomenon I use optogenetic activation of GABAergic interneurons to show that interneurons can drive epileptiform discharges during SE-like activity in vitro. Finally, I confirm that during seizure-like events there is a transient shift in GABAergic signaling that is caused by activity driven changes in the transmembrane Cl⁻ gradient. This thesis provides insight into how excitatory GABAergic signaling during prolonged seizures may contribute towards benzodiazepine resistance in SE. I believe that these results are relevant for understanding of the pathophysiology of SE and may help inform optimal treatment protocols for this condition. 2018-05-03T12:23:56Z 2018-05-03T12:23:56Z 2018 Master Thesis Masters MSc (Med) http://hdl.handle.net/11427/27886 eng application/pdf Division of Medical Biochemistry and Structural Biology Faculty of Health Sciences University of Cape Town
spellingShingle Medical Biochemistry
Burman, Richard J
Investigating excitatory GABAergic signalling & benzodiazepine resistance in an in vitro model of status epilepticus
thesis_degree_str Master's
title Investigating excitatory GABAergic signalling & benzodiazepine resistance in an in vitro model of status epilepticus
title_full Investigating excitatory GABAergic signalling & benzodiazepine resistance in an in vitro model of status epilepticus
title_fullStr Investigating excitatory GABAergic signalling & benzodiazepine resistance in an in vitro model of status epilepticus
title_full_unstemmed Investigating excitatory GABAergic signalling & benzodiazepine resistance in an in vitro model of status epilepticus
title_short Investigating excitatory GABAergic signalling & benzodiazepine resistance in an in vitro model of status epilepticus
title_sort investigating excitatory gabaergic signalling benzodiazepine resistance in an in vitro model of status epilepticus
topic Medical Biochemistry
url http://hdl.handle.net/11427/27886
work_keys_str_mv AT burmanrichardj investigatingexcitatorygabaergicsignallingbenzodiazepineresistanceinaninvitromodelofstatusepilepticus